Veracyte Inc. DEF 14A: Executive Compensation Details

Ticker: VCYT · Form: DEF 14A · Filed: Apr 29, 2025 · CIK: 1384101

Veracyte, Inc. DEF 14A Filing Summary
FieldDetail
CompanyVeracyte, Inc. (VCYT)
Form TypeDEF 14A
Filed DateApr 29, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, executive-compensation, corporate-governance

TL;DR

Veracyte's 2025 DEF 14A drops, showing exec comp details & equity awards for Stapley & Anderson through 2024.

AI Summary

Veracyte, Inc. filed a DEF 14A on April 29, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and related party transactions, including equity awards granted to members like StapleyMember and AndersonMember across various fiscal years from 2020 to 2024.

Why It Matters

This filing provides transparency into how Veracyte, Inc. compensates its top executives and board members, which can influence investor decisions regarding corporate governance and shareholder value.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of executive compensation and does not inherently present new financial risks.

Key Players & Entities

  • VERACYTE, INC. (company) — Filer
  • StapleyMember (person) — Executive/Director
  • AndersonMember (person) — Executive/Director
  • 2024-12-31 (date) — Fiscal Year End
  • 20250429 (date) — Filing Date

FAQ

What is the primary purpose of this DEF 14A filing for Veracyte, Inc.?

The primary purpose of this DEF 14A filing is to provide information regarding the solicitation of proxies for the company's annual meeting of stockholders, including details on executive compensation, director nominations, and other corporate governance matters.

What fiscal period does this filing primarily cover?

This filing covers the fiscal year ending December 31, 2024, with historical data presented for previous years as well.

Who are some of the individuals mentioned in relation to equity awards?

Individuals such as 'StapleyMember' and 'AndersonMember' are mentioned in relation to equity awards granted during the fiscal years 2020 through 2024.

What is Veracyte, Inc.'s standard industrial classification?

Veracyte, Inc.'s standard industrial classification is SERVICES-MEDICAL LABORATORIES [8071].

When was Veracyte, Inc. incorporated and in which state?

Veracyte, Inc. was incorporated in Delaware (DE).

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 29, 2025 by StapleyMember regarding VERACYTE, INC. (VCYT).

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.